See also this year's filing and all EDGAR filings for this company.
PDF Report 0001811623_2024_Kuvatris_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001811623, Kuvatris Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,680,405 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,795,332 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 500,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,230,292 |
| 9 | ResearchAndDevelopmentExpense | 3,914,979 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,144,454 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,680,405 |
| 1 | Liabilities | 2,295,332 |
| 2 | Expenses | 16,145,271 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,385,073 |
| 5 | NetIncome | -18,289,725 |
| 6 | ComprehensiveNetIncome | -18,289,725 |
| 7 | BaseVar | 13,132,731 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.74 |
| 9 | EconomicCapitalRatio | 0.775 |
Edgar->Model Mapping
Feature Distribution
Change over Time
